Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-8487
Authors: Stadler, Nicole
Hasibeder, Astrid
Lopez, Pamela Aranda
Teschner, Daniel
Desuki, Alexander
Kriege, Oliver
Weber, Alexander N. R.
Schulz, Christoph
Michel, Christian
Heβ, Georg
Radsak, Markus
Title: The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation
Online publication date: 7-Dec-2022
Year of first publication: 2017
Language: english
DDC: 610 Medizin
610 Medical sciences
Institution: Johannes Gutenberg-Universität Mainz
Department: FB 04 Medizin
Place: Mainz
ROR: https://ror.org/023b0x485
DOI: http://doi.org/10.25358/openscience-8487
Version: Published version
Publication type: Zeitschriftenaufsatz
License: In Copyright
Information on rights of use: http://rightsstatements.org/vocab/InC/1.0/
Journal: Haematologica
102
5
Pages or article number: e191
e194
Publisher: Ferrata Storti Found
Publisher place: Pavia
Issue date: 2017
ISSN: 1592-8721
0390-6078
Publisher URL: http://dx.doi.org/10.3324/haematol.2016.152017
Publisher DOI: 10.3324/haematol.2016.152017
Appears in collections:DFG-OA-Publizieren (2012 - 2017)

Files in This Item:
  File Description SizeFormat
Thumbnail
the_bruton_tyrosine_kinase_in-20220612163459813.pdf1.14 MBAdobe PDFView/Open